Latest Breaking News On - John paul waymack moleculin - Page 1 : comparemela.com

Moleculin Biotech (MBRX) Announces Publication of Data from Successful European Phase 1 Trial of Annamycin

Moleculin Biotech (MBRX) Announces Publication of Data from Successful European Phase 1 Trial of Annamycin
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomWolfram dempke moleculinPriebe moleculinLiposomal annamycinJohn paul waymack moleculinWalter klempJenene thomasBritish journal of cancer researchExchange commissionDrug administrationSecurities exchangeMoleculin biotech incMoleculin biotechAfter induction therapyBritish journalEuropean chief medical officer

Moleculin Announces Publication of Data from Successful European Phase 1 Trial Evaluating Annamycin as Single Agent Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)

/PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug.

United kingdomUnited statesJenene thomasWalter klempJohn paul waymack moleculinLiposomal annamycinPriebe moleculinWolfram dempke moleculinExchange commissionDrug administrationSecurities exchangeBritish journal of cancer researchMoleculin biotech incBritish journalMoleculin biotechAfter induction therapy